Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C (HCV)”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02441283
What this trial is testing

Assess Resistance and Durability of Response to ABT-493 and/or ABT-530

Who this might be right for
Hepatitis C
AbbVie 384
Early research (Phase 1)Study completedNCT00314054
What this trial is testing

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

Who this might be right for
Hepatitis CHepatic Insufficiency
Wyeth is now a wholly owned subsidiary of Pfizer 27
Testing effectiveness (Phase 2)Study completedNCT01984294
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 101
Post-approval studies (Phase 4)Study completedNCT00207402
What this trial is testing

Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

Who this might be right for
Hepatitis C
Brooke Army Medical Center 34
Testing effectiveness (Phase 2)Study completedNCT02292719
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
AbbVie 70
Large-scale testing (Phase 3)Study completedNCT00705432
What this trial is testing

Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 1,472
Post-approval studies (Phase 4)Study completedNCT00202839
What this trial is testing

Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Study completedNCT03022981
What this trial is testing

Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 216
Testing effectiveness (Phase 2)Study completedNCT02332707
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 443
Post-approval studies (Phase 4)Study completedNCT01222611
What this trial is testing

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Who this might be right for
Chronic HIV InfectionHCV Coinfection
Fundacion SEIMC-GESIDA 42
Large-scale testing (Phase 3)Study completedNCT03092375
What this trial is testing

Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

Who this might be right for
Hepatitis CHCV
University of Florida 177
Not applicableStudy completedNCT01711164
What this trial is testing

The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral Hepatitis

Who this might be right for
Chronic Hepatitis C Infection
University Health Network, Toronto 106
Post-approval studies (Phase 4)Study completedNCT00028093
What this trial is testing

Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Not applicableUnknownNCT03481036
What this trial is testing

DAA Therapy in Pediatric Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis c
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Large-scale testing (Phase 3)Study completedNCT03537274
What this trial is testing

Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 1,224
Large-scale testing (Phase 3)Ended earlyNCT02762383
What this trial is testing

Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)

Who this might be right for
HIV/HCV Coinfection
Hoffmann-La Roche 19
Not applicableEnded earlyNCT00725842
What this trial is testing

Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)

Who this might be right for
Hepatitis CHepatitis C, Chronic
Merck Sharp & Dohme LLC 97
Early research (Phase 1)Study completedNCT03341988
What this trial is testing

Evaluation of Treatment of Chronic HCV Patients in Chronic Kidney Disease Versus End Stage Renal Disease Patients

Who this might be right for
Hepatitis C
Assiut University 100
Post-approval studies (Phase 4)Study completedNCT00546442
What this trial is testing

Treatment Insulin Resistence in HCV G-1 Patient

Who this might be right for
Chronic Hepatitis C
Valme University Hospital 126
Large-scale testing (Phase 3)Study completedNCT00502086
What this trial is testing

Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

Who this might be right for
CirrhosisChronic Hepatitis C
Catalysis SL 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation